To justify the concept of utilizing the enhanced macropinocytosis pathway as an efficientstrategy for targeting drug delivery to the Ras-activated cancer cells, here weapplied ApoE-rHDL as the drug delivery nanocarrier and glioblastoma as the diseasemodel. This evidence concerns the gene APOE and glioblastoma.